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Introduction

1
The sex difference in the pathogenesis of many immune-related disorders, such as autoimmune diseases 2
(1), may be related to the profound immune-modulatory actions of sex hormones. While the complex 3 actions of estrogens in the immune system have been studied in considerable detail (2), less attention has 4 been focused on the actions of androgens, which also are powerful regulators in the immune system (3). 5
For example, androgens modulate humoral immunity (4-6) and bone marrow B lymphopoiesis in males 6 (6-13). 7 8 Identification of the target cells for the diverse actions of sex hormones may provide important insight as 9 well as tools to elucidate the specific roles of sex hormones in immune-related disorders. Several studies 10 have attempted to dissect how androgens suppress bone marrow B lymphopoiesis, e.g. by using mouse 11 models of androgen deficiency (castration) or androgen receptor (AR) knockout (ARKO) mice (6, 11) . 12 However, the results are contradictory and a plausible mechanism for the regulation of B lymphopoiesis 13 by androgens has not been presented. For example, there are conflicting data whether this is an intrinsic 14 effect of the hematopoietic compartment or an extrinsic effect mediated via non-hematopoietic stromal 15 cells (6, 11) . 16
17
The aim of this study was to determine the target cell for androgen-mediated regulation of B 18 lymphopoiesis in male mice. Based on previous data identifying osteoblast-lineage cells as important 19 regulators of B lymphopoiesis (11, 14) , we hypothesized that androgens regulate bone marrow B 20 lymphopoiesis by targeting cells of the osteoblast lineage. 21 was imaged with an X-ray tube voltage of 50 kV and current of 201 μA, with a 0.5-mm aluminum filter. 1
The scanning angular rotation was 180° and the angular increment 0.70°. The voxel size was 4.48 μm 2 isotropically. The NRecon (version 1.6.9) was employed to perform the reconstruction following the 3 scans. In the femur, the trabecular bone proximal to the distal growth plate was selected for analyses 4 within a conforming volume of interest (cortical bone excluded) commencing at a distance of 426.5 μm 5 from the growth plate, and extending a further longitudinal distance of 134.5 μm in the proximal direction. 6
Cortical measurements were performed in the diaphyseal region of the femur starting at a distance of 5.08 7 mm from the growth plate and extending a further longitudinal distance of 448.5 μm in the proximal 8 direction. For BMD analysis, the equipment was calibrated with ceramic standard samples. In the 9 vertebra, the trabecular bone in the vertebral body caudal of the pedicles was selected for analyses within 10 a conforming volume of interest (cortical bone excluded) commencing at a distance of 4.48 μm caudal of 11 the lower end of the pedicles, and extending a further longitudinal distance of 134.5 μm in the caudal 12 direction. Trabecular thickness and separation were calculated by the sphere-fitting local thickness 13 method. 14 15
Dual Energy X-ray Absorptiometry (DXA) 16
Analyses of total body areal bone mineral density (aBMD) and bone mineral content (BMC) were 17 performed by DXA using the Lunar PIXImus mouse densitometer (Wipro GE Healthcare, Madison, WI, 18
USA)(25). 19 20
Bone turnover markers 21
The bone formation markers osteocalcin and bone resorption marker C-terminal cross-linked telopeptide 22 of collagen type I (CTX-I) were measured in serum using ELISA kits (Mouse Osteocalcin ELISA kit, 23 #60-1305, Immutopics Inc., San Clemente, CA, USA; RatLaps TM EIA, Immunodiagnostic Systems Ltd, 24
Boldon, United Kingdom) according to the manufacturer's instructions. 25
Statistical analyses 1
All data represent mean ± SEM. Statistical evaluations were performed with Prism software (version 6, 2 GraphPad Software, Inc., San Diego, CA, USA) and the non-parametrical Mann-Whitney U test was used 3 for two-group comparisons. A p-value of <0.05 was considered statistically significant. 4
Results
1
Increased bone marrow B lymphopoiesis in mice with global deletion of the androgen receptor (G-2
ARKO) 3
To confirm the importance of the AR for B lymphopoiesis in males, we first analyzed the bone marrow 4 from mice with a global deletion of the AR (G-ARKO). There were an increased number of lymphocytes 5 and a reduced number of granulocytes, while the total number of cells in the femoral bone marrow did not 6 differ between G-ARKO and Pgk-Cre + littermate controls (Supplemental Figure 2 and Supplemental 7 Table 1 ). 8
The number of B220 +
CD19
+ B cells in the bone marrow of G-ARKO was increased compared to controls 9 (+80%, Figure 1A we hypothesized that androgens may exert their effect on B lymphopoiesis by targeting these cells. We 18 therefore generated and characterized osteoblast-lineage cell-specific ARKO (O-ARKO) male mice. 19
Analyzing the efficiency of AR deletion in these mice, we observed a 50% reduction of AR gDNA in the 20 femur shaft of O-ARKO mice vs. Osx1-Cre + littermate controls (Figure 2A ), confirming a satisfactory 21 deletion of AR in osteoblast-lineage cells. We could also corroborate a tissue-specific deletion, as none ofthe other analyzed tissues showed reduced AR gDNA levels (Supplemental Figure 3) . 23
To assess the androgen status of G-and O-ARKO mice, we recorded the wet weights of the seminal 24 vesicles and the testes. As previously published (15), the male G-ARKO mice had much lower seminal 25 vesicle and testes wet weights compared to littermate controls, displaying a general androgen insensitivityphenotype ( Figure 2B ). In O-ARKO, the seminal vesicle and testis weights did not differ from control 1 mice ( Figure 2B ), indicating a normal androgen level and peripheral AR action in these mice. 2
Androgens are important regulators of bone homeostasis in males, and androgen/AR-deficient male mice 3 are osteopenic, with a reduction of both trabecular and cortical bone mass (27) . To verify the effects on 4 bone in O-ARKO, trabecular and cortical bone parameters were analyzed. The trabecular number, 5 assessed by μCT, was significantly reduced in vertebrae ( Figure 2C-D) and a similar non-significant trend 6 was observed in femur in O-ARKO compared to control mice ( Figure 2C ). In contrast, neither cortical 7 bone mass, as indicated by femoral cortical bone thickness ( Figure 2E ) and cortical volumetric BMD 8 (Supplemental Table 2 ), nor trabecular thickness in vertebrae/femur (Supplemental Table 2 ) were 9 significantly affected in O-ARKO mice. Analyses of aBMD and BMC using DXA, by which trabecular 10 and cortical bone compartments cannot be separated, did not reveal any significant reduction in bone mass 11 in O-ARKO mice (Table S2) . Bone turnover was assessed by measuring serum concentration of 12 osteocalcin and CTX-I (type I collagen fragments), which are markers for bone formation and resorption, 13 respectively. O-ARKO mice had increased serum levels of both osteocalcin and CTX-I in serum 14 Previously published data on androgen-and AR-mediated inhibition of bone marrow B lymphopoiesis are 7 consistent (6-11). However, there have been conflicting reports regarding the target cell(s) for this effect. 8
Altuwaijri et al. suggested the effect to be B cell-intrinsic, using a B cell-specific ARKO mouse (CD19-9 driven Cre expression) (6). In contrast, Olsen et al. suggested a non-hematopoietic target cell, using a bone 10 marrow transplantation approach (11). Our present data support the notion of a non-hematopoietic target 11 cell. Furthermore, we could specify that AR in osteoblast-lineage cells regulates bone marrow B 12 lymphopoiesis. As the O-ARKO bone marrow B lymphopoiesis pattern mimics that of G-ARKO, our data 13 clearly show that the osteoprogenitor/osteoblast niche is a likely target for this androgen-mediated effect. 14 Our data are supported by previous studies demonstrating a pivotal role of osteoblast-lineage cells 15 supporting B lymphopoiesis (14, 26, (28) (29) (30) (31) . The exact mechanism for androgen/AR regulation of B 16 lymphopoiesis remains to be elucidated, but cytokines (such as IL-7, SCF, or CXCL12) known to be 17 secreted from the osteoblast-lineage cells are candidates for mediating the suppressive effect (14, 32) . In the present study, we found that G-ARKO mice had unchanged total number of bone marrow nucleated 4 cells, while these were increased in the O-ARKO model. Therefore, we analyzed the number of cells in 5 other hematopoietic cell populations. While the use of forward and side scatter for the definition of bone 6 marrow cell subsets should be considered as a study limitation, our finding of reduced number of 7 granulocyte-like cells in the bone marrow of G-ARKO mice is in line with a previously published report 8
showing that G-ARKO mice are neutropenic and have reduced granulopoiesis (33). Because this effect on 9 bone marrow granulocyte number was not seen in O-ARKO mice, differential effects on granulopoiesis in 10 the G-ARKO and O-ARKO models may contribute to the discrepancy in total bone marrow cell number. 11
Further, these data suggest that the bone marrow granulopenia in AR deficiency is less likely to be 12 osteoblast-lineage cell-dependent. In the present study, we found that AR deficiency in osteoblast-lineage cells moderately reduced the 4 number of bone trabeculae in the vertebrae while cortical bone mass was unaffected. As the cortical bone 5 compartment is more important than the trabecular bone compartment for overall bone mass, it is not 6 surprising that the total body BMC as analyzed by DXA was not significantly affected in the O-ARKO 7 mice. Our data are consistent with results from previous cell-specific ARKO models (recently reviewed 8 (27)), which have been generated to evaluate the effects of AR in osteoblasts and osteocytes, respectively. 9
These models show a role of the AR in mature osteoblast-lineage cells for trabecular but not cortical bone 10 (35-37). Our data add to previous results by comprising the immature osteoblast-lineage cells; hence, AR 11 neither in early osteoprogenitors cells nor in mature osteoblast-lineage cells has an impact on cortical 12 bone. O-ARKO mice had elevated serum levels of markers for both bone formation and bone resorption, 13
suggesting that the reduced trabecular number primarily is the result of elevated bone resorption. Taken 14 together, the present and previous results demonstrate that trabecular bone is regulated by AR in 15 osteoblast-lineage cells, while the target cell for AR-mediated effects on cortical bone mass is still to be 16 identified (27, 38) . 17
18
The bone and the bone marrow are intimately connected, both spatially and functionally, and androgens 19 have a major impact on both tissues. B lymphocytes are thought to contribute to the bone loss caused by 20 sex steroid deficiency (38), which is supported by the concurrent bone loss and increased bone marrow B 21 lymphopoiesis after castration and IL-7 treatment, respectively. Immature, but not mature, B cells are 22 suggested to mediate the osteopenic effect through RANKL, and RANKL-deficient B cells cannot induce 23 bone loss after castration. Additional investigations are needed to evaluate if the osteoblast-lineage cell-24 specific AR effect on trabecular bone is mediated via inhibition of B lymphopoiesis. Further, it is yet 25 unclear if and how B cell-intrinsic androgen signaling may affect cortical and/or trabecular bone.
1
The fact that androgen deficiency in men is associated with increased risk of autoimmunity indicates a 2 clinically important role of androgens in regulating autoimmunity (39, 40) . This effect of androgen 3 deficiency is mirrored in rodent experimental models of autoimmune disease (41,42). To date, the 4 androgenic actions resulting in protection from autoimmunity remain unclear. However, it is reasonable to 5 believe that the observed protection against autoimmunity may somehow be related to the actions of 6 androgens as potent regulators of B cell homeostasis in both humans and rodents (13). Our novel finding 
Supplemental table 1
Hematopoietic cell subsets in bone marrow of G-and O-ARKO mice 
